Home > Boards > US Listed > Medical - Drugs > AcelRx Pharmaceuticals, Inc. (ACRX)

looks like Oppenheimer conference wasn't a big deal

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Bobwins Member Profile
Member Level 
Followed By 528
Posts 17,213
Boards Moderated 42
Alias Born 10/21/03
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 7:06:37 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 7:05:26 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 7:03:55 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 7:03:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 7:01:25 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 6:59:29 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/25/2019 4:50:33 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/6/2019 6:06:27 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/3/2019 7:11:14 AM
AcelRx announces the closing of a $25 million senior secured debt facility PR Newswire (US) - 6/3/2019 7:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 5/14/2019 6:11:56 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 5/14/2019 6:11:08 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 5/9/2019 8:56:02 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/9/2019 8:53:27 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/8/2019 4:06:39 PM
AcelRx Pharmaceuticals Reports First Quarter 2019 Financial Results PR Newswire (US) - 5/8/2019 4:01:00 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 5/3/2019 5:06:22 PM
Amended Annual Report (10-k/a) Edgar (US Regulatory) - 4/30/2019 6:34:09 AM
AcelRx to announce first quarter 2019 results and provide an update on the company's business on Wednesday, May 8th, 2019 PR Newswire (US) - 4/25/2019 4:05:00 PM
AcelRx Pharmaceutical's pooled safety results for sufentanil sublingual tablets (DSUVIA) selected for presentation at 44th An... PR Newswire (US) - 4/11/2019 4:37:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/12/2019 2:17:20 PM
AcelRx Pharmaceuticals to Present at Oppenheimer & Co. Inc. 29th Annual Healthcare Conference PR Newswire (US) - 3/11/2019 4:01:00 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 3/7/2019 5:58:54 PM
Annual Report (10-k) Edgar (US Regulatory) - 3/7/2019 5:58:53 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/7/2019 4:06:54 PM
Bobwins Member Level  Wednesday, 03/20/19 03:44:35 PM
Re: Bobwins post# 1110
Post # of 1158 
looks like Oppenheimer conference wasn't a big deal for ACRX. Price actually went down after start of presentation.

Guess attendees weren't that excited about ACRX chances with new drug launch. May be in a show me stance due to Opiod negative publicity.



Please post stock symbols first in all your posts. If it's a foreign stock, please list the US pk equivalent symbol.

If the Commodities Boom is Over, I am just a Gold Bug headed for the Windshield of LIFE
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist